Credit Rating

fUBIIAJVr PHARMOVA October 21, 2026 BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers Exchange Plaza Dalal Street, Fort Bandra Kurla Complex, Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 530019 Symbol: JUBLPHARMA Sub.: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Credit rating assigned by India Ratings and Research Pvt Ltd for proposed Non-Convertible Debentures Dear Sir/Madam, Pursuant to Regulation 30 read with Part A of Schedule III of the Listing Regulations, we hereby inform you that India Ratings and Research Pvt Ltd ("India Ratings") has assigned the following credit rating to the Company’s proposed non-convertible debentures: Instrument Amount(₹ crore) Rating Action Proposed Non-Convertible Debentures 1,400.00 IND AA+/Stable (Assigned) The aforesaid rating has been assigned vide India Ratings letter dated October 21, 2026, which is enclosed herewith. Date and time of receipt of the rating communication: October 21, 2026, at 11:47 A.M. (IST). The rating letter is enclosed, and this disclosure is also being made available on the Company’s website at www.jubilantpharmova.com. You are requested to take the above information on record. Thanking you, Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary Encl.: India Ratings Credit Rating letter dated October 21, 2026 uA Jubilant Bhartia Company --- 0URVAWES --- Jubilant Pharmova Limited Regd Office: I -A, Sector 16-A, Bhartiagram, Gajraula Noida-20 I 30 I, UP, India Distt. Amroha -244 223 • Tel: +91 120 4361000 UP, India ® Fax +91 120 4234895-96 CIN: L24116UPl978PLC004624 www.jubilantpharmova.com INNOVATION Fitch Group India Ratings &Research A Fitch Group Company Mr. Ashish Mukkirwar Jubilant Pharmova Limited Plot-IA, Sector-16A, Noida - 201301, Uttar Pradesh October 21, 2026 Dear Sir/Madam, Re: Rating Letter for NCD of Jubilant Pharmova Limited India Ratings and Research (Ind-Ra) has rated Jubilant Pharmova Limited's (JPM) proposed non-convertible debentures (NCDs) as follows: Instrument Type Regulator of Date oflssuance Coupon Maturity Size of Rating Rating Instrument Rate Date Issue (INR Assigned with Action million) Outlook/Watch Proposed non- SEBI - - - 14,000 IND AA+/Stable Assigned convertible debentures In issuing and maintaining its ratings, India Ratings relies on factual information it receives from issuers and underwriters and from other sources India Ratings believes to be credible. India Ratings conducts a reasonable investigation of the factual information relied upon by it in accordance with its ratings methodology, and obtains reasonable verification of that information from independent sources, to the extent such sources are available for a given security. The manner of India Ratings factual investigation and the scope of the third-party verification it obtains will vary depending on the nature of the rated security and its issuer, the requirements and practices in India where the rated security is offered and sold, the availability and nature of relevant public information, access to the management of the issuer and its advisers, the availability of pre-existing third-party verifications such as audit reports, agreed-upon procedures letters, appraisals, actuarial reports, engineering reports, legal opinions and other reports provided by third parties, the availability of independent and competent third-party verification sources with respect to the particular security or in the particular jurisdiction of the issuer, and a variety of other factors. Users of India Ratings ratings should understand that neither an enhanced factual investigation nor any third-party verification can ensure that all of the information India Ratings relies on in connection with a rating will be accurate and complete. Ultimately, the issuer and its advisers are responsible for the accuracy of the information they provide to India Ratings and to the market in offering documents and other reports. In issuing its ratings India Ratings must rely on the work of experts, including independent auditors with respect to financial statements and attorneys with respect to legal and tax matters. Further, ratings are inherently forward-looking and embody assumptions and predictions about future events that by their nature cannot be verified as facts. As a result, despite any verification of current facts, ratings can be affected by future events or conditions that were not anticipated at the time a rating was issued or affrrmed India Ratings seeks to continuously improve its ratings criteria and methodologies, and periodically updates the descriptions on its website of its criteria and methodologies for securities of a given type. The criteria and methodology used to determine a rating action are those in effect at the time the rating action is taken, which for public ratings is the date of the related rating action commentary. Each rating action commentary provides information about the criteria and methodology used to arrive at the stated rating, which may differ from the general criteria and methodology for the applicable security type posted on the website at a given time. For this reason, you should always consult the applicable rating action commentary for the most accurate information on the basis of any given public rating. Ratings are based on established criteria and methodologies that India Ratings is continuously evaluating and updating. Therefore, ratings are the collective work product of India Ratings and no individua~ or group of individuals, is solely responsible for a rating. All India Ratings reports have shared authorship. Individuals identified in an India Ratings report were involved in, but are not solely responsible for, the opinions stated therein. The individuals are named for contact purposes only. ~gs are not a recommendation or suggestion, directly or indirectly, to you or any other person, to buy, sell, make or hold any investment, loan or security or to undertake any investment strategy with respect to any investment, loan or security or any issuer. Ratings do not comment on the adequacy of market price, the suitability of any investment, loan or security for a particular investor (including without Fitch Group India Ratings &Research A Fitch Group Company limitation, any accounting and/or regulatory treatment), or the tax-exempt nature or taxability of payments made in respect of any investment, loan or security. India Ratings is not your advisor, nor is India Ratings providing to you or any other party any financial advice, or any legal, auditing, accounting, appraisal, valuation or actuarial services. A rating should not be viewed as a replacement for such advice or services. Investors may fmd India Ratings ratings to be important information, and India Ratings notes that you are responsible for communicating the contents of this letter, and any changes with respect to the rating, to investors. It will be important that you promptly provide us with all information that may be material to the ratings so that our ratings continue to be appropriate. Ratings may be raised, lowered, withdrawn, or placed on Rating Watch due to changes in, additions to, accuracy of or the inadequacy of information or for any other reason India Ratings deems sufficient. Nothing in this letter is intended to or should be construed as creating a fiduciary relationship between India Ratings and you or between India Ratings and any user of the ratings. In this letter, "India Ratings" means India Ratings & Research Pvt. Ltd. and any successor in interest. We are pleased to have had the opportunity to be of service to you. If we can be of further assistance, please email us at infogrp@indiaratings.co. in Sincerely, India Ratings M~hankarlal Director JubilantPharmovaLimited 21-October-2026 Fitch Group India Ratings &Research A Fitch Group Company DISCLAIMER India Ratings and Rese [Showing first 8,000 characters — download PDF for full document]